These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 18826517)
21. [Characteristics of retinal and scleral infiltration in uveal melanoma]. Zhang J; Xu XL; Li B; Wei WB Zhonghua Yan Ke Za Zhi; 2016 Oct; 52(10):749-754. PubMed ID: 27760647 [No Abstract] [Full Text] [Related]
22. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma. El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149 [TBL] [Abstract][Full Text] [Related]
23. JARID1B protein expression and prognostic implications in uveal melanoma. Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717 [TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005 [TBL] [Abstract][Full Text] [Related]
25. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins. Elshaw SR; Sisley K; Cross N; Murray AK; MacNeil SM; Wagner M; Nichols CE; Rennie IG Br J Ophthalmol; 2001 Jun; 85(6):732-8. PubMed ID: 11371496 [TBL] [Abstract][Full Text] [Related]
26. Expression of cyclin-D1 in uveal malignant melanoma. Errico ME; Staibano S; Tranfa F; Bonavolonta G; Lo Muzio L; Somma P; Lucariello A; Mansueto G; D'Aponte A; Ferrara G; De Rosa G Anticancer Res; 2003; 23(3B):2701-6. PubMed ID: 12894561 [TBL] [Abstract][Full Text] [Related]
27. Differential expression of tissue inhibitor of matrix metalloproteinases 3 in uveal melanoma. Nareyeck G; Zeschnigk M; von der Haar D; Schilling H; Bornfeld N; Anastassiou G Ophthalmic Res; 2005; 37(1):23-8. PubMed ID: 15637418 [TBL] [Abstract][Full Text] [Related]
28. Panophthalmitis with acute scleral necrosis after brachytherapy of a malignant melanoma of the ciliary body. Bodanowitz S; Strempel I; Wiegand W; Kroll P Ger J Ophthalmol; 1995 Nov; 4(6):380-2. PubMed ID: 8751105 [TBL] [Abstract][Full Text] [Related]
29. [Malignant choroidal melanoma with secondary invasion of the sclera]. Craitoiu S Oftalmologia; 1994; 38(1):32-6. PubMed ID: 8155617 [TBL] [Abstract][Full Text] [Related]
30. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines. Docampo MJ; Cabrera J; Rabanal RM; Bassols A Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067 [TBL] [Abstract][Full Text] [Related]
31. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741 [TBL] [Abstract][Full Text] [Related]
32. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium. Woodward JK; Rennie IG; Burn JL; Sisley K Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3473-7. PubMed ID: 16186321 [TBL] [Abstract][Full Text] [Related]
33. Influence of cultured dermal fibroblasts on human melanoma cell proliferation, matrix metalloproteinase-2 (MMP-2) expression and invasion in vitro. Ntayi C; Hornebeck W; Bernard P Arch Dermatol Res; 2003 Nov; 295(6):236-41. PubMed ID: 14530987 [TBL] [Abstract][Full Text] [Related]
34. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Daniels KJ; Boldt HC; Martin JA; Gardner LM; Meyer M; Folberg R Lab Invest; 1996 Jul; 75(1):55-66. PubMed ID: 8683940 [TBL] [Abstract][Full Text] [Related]
35. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Heindl LM; Hofmann TN; Knorr HL; Rummelt C; Schrödl F; Schlötzer-Schrehardt U; Holbach LM; Naumann GO; Kruse FE; Cursiefen C Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383 [TBL] [Abstract][Full Text] [Related]
36. CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas. Lüke J; Vukoja V; Brandenbusch T; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Tura A BMC Ophthalmol; 2016 Jun; 16():74. PubMed ID: 27255356 [TBL] [Abstract][Full Text] [Related]
37. [Expressions of collagen , matrix metalloproteases-2, and tissue inhibitor of matrix metalloproteinase-2 in the posterior sclera of newborn guinea pigs with negative lens-defocused myopia]. Yang SR; Ye JJ; Long Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):55-9. PubMed ID: 20236589 [TBL] [Abstract][Full Text] [Related]
38. The uveal effusion syndrome and trans-scleral flow. Forrester JV; Lee WR; Kerr PR; Dua HS Eye (Lond); 1990; 4 ( Pt 2)():354-65. PubMed ID: 2379646 [TBL] [Abstract][Full Text] [Related]
39. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study. Mallikarjuna K; Pushparaj V; Biswas J; Krishnakumar S Curr Eye Res; 2007 Mar; 32(3):281-90. PubMed ID: 17453948 [TBL] [Abstract][Full Text] [Related]
40. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers. Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]